BCL2A1 Gene

BCL2A1 Gene

Overview

BCL2A1 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BCL2A1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>BCL2A1</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>BFL-1, A1, GRS</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q24.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>602</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9GZW8</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>BCL2 family (anti-apoptotic)</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low (inducible)</td>
</tr>
<tr>
<td class="label">[Microglia](/cell-types/microglia-neuroinflammation)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Hematopoietic cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/leukemia" style="color:#ef9a9a">Leukemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>

BCL2A1 is a human gene whose product bCL2A1 encodes an anti-apoptotic protein that regulates the intrinsic (mitochondrial) [apoptosis](/entities/apoptosis) pathway:. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

BCL2A1 (BCL2-Related Protein A1) is a gene encoding an anti-apoptotic protein member of the BCL2 family. BCL2A1 plays a critical role in regulating mitochondrial apoptosis pathways, neuronal survival, and neuroinflammation. Dysregulation of BCL2A1 is implicated in Alzheimer's disease, Parkinson's disease, and ALS, making it a key gene in understanding neurodegenerative processes["@bcla2005"][@bcl2008].

Gene Overview

BCL2A1 is located on chromosome 15q24.2 and encodes a mitochondrial anti-apoptotic protein. Unlike other BCL2 family members, BCL2A1 is primarily expressed in hematopoietic cells but is also induced in [neurons](/entities/neurons) under stress conditions[@bcla2010].

Normal Function

BCL2A1 encodes an anti-apoptotic protein that regulates the intrinsic (mitochondrial) apoptosis pathway:

Mitochondrial Outer Membrane Permeabilization (MOMP)

• Inhibiting pro-apoptotic BCL2 family proteins (BAX, BAK, BOK)
• Sequestering BH3-only proteins (BIM, BAD, BID)
• Preserving mitochondrial membrane integrity
• Preventing cytochrome c release

Neuronal Survival

• Oxidative stress-induced apoptosis
• [Excitotoxicity](/mechanisms/excitotoxicity)
• Mitochondrial dysfunction
• Neurotrophic factor withdrawal

Regulation of Autophagy

• Modulates Beclin-1 function
• Links apoptosis and autophagy pathways
• Affects protein aggregate clearance

Role in Neurodegenerative Diseases

Alzheimer's Disease

BCL2A1 dysregulation contributes to AD pathogenesis through several mechanisms[@bcl2012][@antiapoptotic2014]:

[Amyloid-beta](/proteins/amyloid-beta) toxicity:

• BCL2A1 expression is altered in AD brains
• May affect neuronal vulnerability to Aβ toxicity
• Interactions with [APP](/entities/app-protein) processing

• Anti-apoptotic function may be overwhelmed in tauopathies
• Relationship between tau and BCL2 family proteins

• Microglial BCL2A1 affects inflammatory responses
• Cross-talk between apoptosis and neuroinflammation

Parkinson's Disease

In PD, BCL2A1 plays a protective role against dopaminergic neuron loss[@bcl2013][@mitochondrial2015]:

[Alpha-synuclein](/proteins/alpha-synuclein) toxicity:

• BCL2A1 may protect against α-synuclein-induced apoptosis
• Altered expression in substantia nigra

• Protects against complex I inhibitors (MPTP, rotenone)
• Maintains mitochondrial integrity in dopaminergic neurons

• Guards against [ROS](/entities/reactive-oxygen-species)-induced neuronal death
• Upregulated in response to oxidative stress

Amyotrophic Lateral Sclerosis (ALS)

BCL2A1 involvement in ALS includes[@bcl2016]:

Motor neuron survival:

• Protects against excitotoxicity
• Modulates SOD1 toxicity

• Affects astrocyte-mediated toxicity
• Alters microglial inflammatory responses

Other Neurodegenerative Diseases

• Huntington's Disease: Modified polyglutamine toxicity response
• Frontotemporal Dementia: Altered neuronal stress responses
• Prion Disease: Prion-induced apoptosis modulation

Expression Pattern

BCL2A1 expression in the nervous system:

Expression is inducible in neurons by:

• Oxidative stress
• Cytokine signaling
• Growth factor withdrawal
• DNA damage

Therapeutic Implications

BCL2A1 represents a potential therapeutic target[@targeting2019]:

Small Molecule Activators

• BCL2A1-specific activators under development
• BH3 mimetics targeting BCL2A1

Gene Therapy Approaches

• Viral vector-mediated BCL2A1 overexpression
• CRISPR-based targeting

Combination Strategies

• Combined with other anti-apoptotic proteins
• With neurotrophic factors

Cross-Links

• [BCL2 Gene](/genes/bcl2)
• [Apoptosis Pathway](/mechanisms/apoptosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [BCL2 Family Proteins](/proteins/bcl2-family-protein)

See Also

• [ Protein](/proteins/bcl2-family-protein)
• [Apoptosis Pathway](/mechanisms/apoptosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References